Celldex Therapeutics
CLDX
#4494
Rank
โ‚น231.70 B
Marketcap
โ‚น2,950
Share price
5.16%
Change (1 day)
46.82%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -โ‚น197.01

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น408.54. In 2022 the company made an earnings per share (EPS) of -โ‚น224.46 a decrease over its 2021 EPS that were of -โ‚น154.03.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น197.01-12.23%
2022-โ‚น224.4645.73%
2021-โ‚น154.03-23.36%
2020-โ‚น200.98-41.05%
2019-โ‚น340.92-76.95%
2018-โ‚น1,47945.03%
2017-โ‚น1,020-42.54%
2016-โ‚น1,775-3.82%
2015-โ‚น1,845-0.76%
2014-โ‚น1,86029.41%
2013-โ‚น1,4370%
2012-โ‚น1,437-9.73%
2011-โ‚น1,5921312.5%
2010-โ‚น112.70-95.79%
2009-โ‚น2,675-49.64%
2008-โ‚น5,311-82.64%
2007-โ‚น30,598-44.98%
2006-โ‚น55,6181270.83%
2005-โ‚น4,05733.33%
2004-โ‚น3,043-10%
2003-โ‚น3,381-16.67%
2002-โ‚น4,057-38.46%
2001-โ‚น6,593-4.88%
2000-โ‚น6,931-81.66%
1999-โ‚น37,783-87.2%
1998-โ‚น2,95,065206.39%
1997-โ‚น96,30313.02%
1996-โ‚น85,212

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น71.38-117.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,523-472.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น270.23-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-โ‚น412.30 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚น376.61-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น189.71-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น323.08-20.92%๐Ÿ‡บ๐Ÿ‡ธ USA